 Rachel Friedman
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 18 | 2022 | 1996 | 2.690 |
Why?
| | Islets of Langerhans | 7 | 2022 | 846 | 1.930 |
Why?
| | Cell Movement | 9 | 2020 | 961 | 1.210 |
Why?
| | Autoimmunity | 8 | 2021 | 936 | 1.180 |
Why?
| | Antigen-Presenting Cells | 7 | 2021 | 159 | 1.110 |
Why?
| | Diabetes Mellitus, Type 1 | 11 | 2022 | 3917 | 1.040 |
Why?
| | CD11c Antigen | 3 | 2019 | 40 | 0.790 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2022 | 917 | 0.760 |
Why?
| | Cell Communication | 5 | 2014 | 326 | 0.730 |
Why?
| | B-Lymphocytes, Regulatory | 1 | 2022 | 3 | 0.720 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2021 | 38 | 0.680 |
Why?
| | Phagocytes | 1 | 2021 | 79 | 0.660 |
Why?
| | Disasters | 1 | 2022 | 102 | 0.650 |
Why?
| | Autoantigens | 4 | 2018 | 426 | 0.610 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 613 | 0.600 |
Why?
| | Stress, Physiological | 2 | 2022 | 452 | 0.560 |
Why?
| | Antigen Presentation | 7 | 2017 | 207 | 0.560 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 185 | 0.550 |
Why?
| | Lymphocyte Activation | 11 | 2022 | 1134 | 0.540 |
Why?
| | Homeostasis | 1 | 2022 | 639 | 0.530 |
Why?
| | B-Lymphocytes | 4 | 2019 | 878 | 0.520 |
Why?
| | Dendritic Cells | 6 | 2018 | 499 | 0.510 |
Why?
| | Coronary Artery Disease | 1 | 2022 | 760 | 0.450 |
Why?
| | Immunological Synapses | 2 | 2013 | 16 | 0.420 |
Why?
| | Cellular Microenvironment | 2 | 2014 | 93 | 0.420 |
Why?
| | Signal Transduction | 7 | 2024 | 5202 | 0.410 |
Why?
| | Animals | 33 | 2024 | 38141 | 0.390 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2014 | 673 | 0.390 |
Why?
| | Lymph Nodes | 5 | 2018 | 502 | 0.390 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1076 | 0.390 |
Why?
| | Hypertension | 1 | 2022 | 1273 | 0.380 |
Why?
| | Peripheral Tolerance | 1 | 2013 | 14 | 0.380 |
Why?
| | Cancer Vaccines | 2 | 2004 | 161 | 0.370 |
Why?
| | Telemedicine | 1 | 2022 | 960 | 0.370 |
Why?
| | Mice | 22 | 2024 | 18338 | 0.350 |
Why?
| | Cell Adhesion Molecules | 3 | 2022 | 181 | 0.340 |
Why?
| | Therapeutic Touch | 1 | 2010 | 3 | 0.330 |
Why?
| | Asthma | 1 | 2022 | 1795 | 0.310 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2018 | 1138 | 0.300 |
Why?
| | Microfilament Proteins | 2 | 2022 | 136 | 0.290 |
Why?
| | Antigens | 3 | 2021 | 349 | 0.290 |
Why?
| | Mice, Inbred C57BL | 10 | 2022 | 5989 | 0.280 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2004 | 175 | 0.280 |
Why?
| | Heart Failure | 1 | 2022 | 2329 | 0.280 |
Why?
| | Listeria monocytogenes | 2 | 2017 | 114 | 0.270 |
Why?
| | Phosphoproteins | 2 | 2022 | 339 | 0.260 |
Why?
| | Regeneration | 1 | 2009 | 198 | 0.260 |
Why?
| | Mice, Knockout | 11 | 2020 | 3125 | 0.250 |
Why?
| | Mice, Transgenic | 6 | 2021 | 2189 | 0.250 |
Why?
| | Acute Coronary Syndrome | 1 | 2010 | 297 | 0.250 |
Why?
| | Chromogranin A | 2 | 2018 | 43 | 0.250 |
Why?
| | Wound Healing | 1 | 2009 | 355 | 0.240 |
Why?
| | Heart Rate | 1 | 2010 | 859 | 0.240 |
Why?
| | Intracellular Fluid | 1 | 2005 | 25 | 0.230 |
Why?
| | Extracellular Fluid | 1 | 2005 | 38 | 0.230 |
Why?
| | Chemokines | 1 | 2006 | 218 | 0.230 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 3 | 2013 | 63 | 0.220 |
Why?
| | Stem Cells | 1 | 2009 | 626 | 0.220 |
Why?
| | Immune Tolerance | 2 | 2021 | 384 | 0.210 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 33 | 0.210 |
Why?
| | Ephrin-B2 | 1 | 2024 | 45 | 0.210 |
Why?
| | High Mobility Group Proteins | 1 | 2004 | 45 | 0.200 |
Why?
| | Epitopes | 1 | 2005 | 480 | 0.200 |
Why?
| | Aging | 2 | 2015 | 1940 | 0.190 |
Why?
| | Nonmuscle Myosin Type IIA | 2 | 2014 | 8 | 0.190 |
Why?
| | Biomedical Research | 1 | 2009 | 718 | 0.190 |
Why?
| | Trans-Activators | 2 | 2009 | 397 | 0.190 |
Why?
| | Actins | 2 | 2022 | 421 | 0.180 |
Why?
| | Cell Adhesion | 4 | 2017 | 452 | 0.180 |
Why?
| | CD11 Antigens | 1 | 2021 | 29 | 0.170 |
Why?
| | HIV Antigens | 1 | 2000 | 17 | 0.160 |
Why?
| | Recombination, Genetic | 2 | 2018 | 205 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 168 | 0.160 |
Why?
| | Conservation of Natural Resources | 1 | 2021 | 133 | 0.160 |
Why?
| | Airway Remodeling | 1 | 2020 | 63 | 0.150 |
Why?
| | Immune System | 2 | 2013 | 178 | 0.150 |
Why?
| | Humans | 21 | 2024 | 145491 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2024 | 562 | 0.150 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.150 |
Why?
| | Adenine | 1 | 2021 | 338 | 0.140 |
Why?
| | Piperazines | 1 | 2021 | 378 | 0.140 |
Why?
| | Neovascularization, Pathologic | 1 | 2020 | 284 | 0.140 |
Why?
| | Myeloid Cells | 1 | 2019 | 146 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 210 | 0.140 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2018 | 48 | 0.130 |
Why?
| | Molecular Imaging | 1 | 2018 | 57 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2004 | 1164 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2018 | 4127 | 0.130 |
Why?
| | Endothelial Cells | 3 | 2020 | 866 | 0.130 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2018 | 132 | 0.130 |
Why?
| | C-Peptide | 1 | 2018 | 190 | 0.130 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2017 | 30 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2022 | 608 | 0.130 |
Why?
| | Interleukin-4 | 1 | 2018 | 208 | 0.130 |
Why?
| | Receptors, Interferon | 1 | 2017 | 60 | 0.130 |
Why?
| | Hospitals | 1 | 2022 | 732 | 0.130 |
Why?
| | Listeriosis | 1 | 2017 | 63 | 0.120 |
Why?
| | Prostatic Neoplasms | 1 | 2004 | 978 | 0.120 |
Why?
| | Ecosystem | 1 | 2021 | 591 | 0.120 |
Why?
| | Spleen | 2 | 2015 | 511 | 0.110 |
Why?
| | Flow Cytometry | 4 | 2015 | 1156 | 0.110 |
Why?
| | Disease Progression | 2 | 2019 | 2862 | 0.110 |
Why?
| | HIV-1 | 1 | 2000 | 905 | 0.100 |
Why?
| | Peptide Fragments | 3 | 2018 | 693 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 951 | 0.100 |
Why?
| | Phenotype | 1 | 2022 | 3157 | 0.100 |
Why?
| | Alum Compounds | 1 | 2013 | 26 | 0.100 |
Why?
| | Gene Expression | 1 | 2018 | 1478 | 0.090 |
Why?
| | Inflammation | 3 | 2020 | 2883 | 0.090 |
Why?
| | Female | 12 | 2021 | 78763 | 0.090 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 70 | 0.090 |
Why?
| | Chemokine CCL21 | 2 | 2015 | 13 | 0.090 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 32 | 0.090 |
Why?
| | Cell Line, Tumor | 3 | 2024 | 3537 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2013 | 246 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 365 | 0.080 |
Why?
| | Internship and Residency | 1 | 2022 | 1265 | 0.080 |
Why?
| | Immunity, Cellular | 1 | 2013 | 273 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2014 | 782 | 0.080 |
Why?
| | Music Therapy | 1 | 2010 | 24 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2004 | 2664 | 0.080 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 2 | 2008 | 27 | 0.080 |
Why?
| | Autoimmune Diseases | 2 | 2018 | 469 | 0.080 |
Why?
| | Fluorescence | 1 | 2010 | 154 | 0.080 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2010 | 63 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2137 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2379 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2004 | 2910 | 0.070 |
Why?
| | Cell Transplantation | 1 | 2009 | 39 | 0.070 |
Why?
| | Macrophages | 1 | 2017 | 1509 | 0.070 |
Why?
| | Self Tolerance | 1 | 2008 | 27 | 0.070 |
Why?
| | Obesity | 1 | 2022 | 3076 | 0.070 |
Why?
| | Hepatocytes | 1 | 2009 | 224 | 0.070 |
Why?
| | Stem Cell Transplantation | 1 | 2009 | 190 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 297 | 0.070 |
Why?
| | Paracrine Communication | 1 | 2008 | 67 | 0.070 |
Why?
| | Lymphoid Tissue | 1 | 2008 | 78 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2582 | 0.060 |
Why?
| | Interleukin-2 | 1 | 2008 | 440 | 0.060 |
Why?
| | Lung | 1 | 2020 | 4103 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 138 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2006 | 48 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2006 | 33 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2018 | 2045 | 0.060 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2006 | 130 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1451 | 0.060 |
Why?
| | Mice, Mutant Strains | 1 | 2006 | 302 | 0.060 |
Why?
| | Mice, Inbred Strains | 1 | 2006 | 396 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 579 | 0.050 |
Why?
| | Mice, Inbred BALB C | 3 | 2015 | 1261 | 0.050 |
Why?
| | Cell Line | 2 | 2020 | 2823 | 0.050 |
Why?
| | Ligands | 1 | 2006 | 667 | 0.050 |
Why?
| | SOXC Transcription Factors | 1 | 2004 | 9 | 0.050 |
Why?
| | Antibodies, Neoplasm | 1 | 2004 | 34 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 2 | 2004 | 573 | 0.050 |
Why?
| | COS Cells | 1 | 2004 | 177 | 0.050 |
Why?
| | Antibody Specificity | 1 | 2004 | 178 | 0.050 |
Why?
| | Carcinoma, Small Cell | 1 | 2004 | 172 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2004 | 196 | 0.050 |
Why?
| | Antigens, CD | 1 | 2006 | 557 | 0.050 |
Why?
| | Recombinant Proteins | 3 | 2002 | 1367 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 211 | 0.050 |
Why?
| | Kallikreins | 1 | 2002 | 26 | 0.050 |
Why?
| | Adoptive Transfer | 2 | 2015 | 199 | 0.040 |
Why?
| | Clone Cells | 2 | 2018 | 264 | 0.040 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 691 | 0.040 |
Why?
| | Transfection | 1 | 2004 | 925 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 156 | 0.040 |
Why?
| | Accreditation | 1 | 2022 | 101 | 0.040 |
Why?
| | Polymerization | 1 | 2022 | 130 | 0.040 |
Why?
| | Prostate-Specific Antigen | 1 | 2002 | 162 | 0.040 |
Why?
| | Male | 8 | 2020 | 72817 | 0.040 |
Why?
| | Listeria | 1 | 2000 | 5 | 0.040 |
Why?
| | Gene Products, nef | 1 | 2000 | 12 | 0.040 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 19 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 441 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2004 | 1049 | 0.040 |
Why?
| | Gene Products, gag | 1 | 2000 | 38 | 0.040 |
Why?
| | AIDS Vaccines | 1 | 2000 | 53 | 0.040 |
Why?
| | Lymphatic System | 1 | 2020 | 15 | 0.040 |
Why?
| | Transcription Factors | 1 | 2008 | 1733 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 737 | 0.040 |
Why?
| | Hospitalization | 1 | 2010 | 2458 | 0.040 |
Why?
| | Alanine | 1 | 2000 | 170 | 0.040 |
Why?
| | Vascular System Injuries | 1 | 2020 | 81 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 335 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2022 | 301 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2018 | 58 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2018 | 125 | 0.030 |
Why?
| | beta Catenin | 1 | 2020 | 253 | 0.030 |
Why?
| | Sex Factors | 1 | 2004 | 2110 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2017 | 84 | 0.030 |
Why?
| | Monocytes | 1 | 2000 | 536 | 0.030 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 42 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1998 | 226 | 0.030 |
Why?
| | Heat-Shock Proteins | 1 | 1998 | 134 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1998 | 177 | 0.030 |
Why?
| | Mice, SCID | 1 | 2018 | 369 | 0.030 |
Why?
| | Germinal Center | 1 | 2018 | 67 | 0.030 |
Why?
| | Pulmonary Emphysema | 1 | 2020 | 277 | 0.030 |
Why?
| | Integrin alpha4 | 1 | 2017 | 7 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2018 | 276 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 564 | 0.030 |
Why?
| | Chemotaxis | 1 | 2017 | 123 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 148 | 0.030 |
Why?
| | Interferon Type I | 1 | 2017 | 147 | 0.030 |
Why?
| | Macrophage Activation | 1 | 2017 | 186 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| | Microsatellite Repeats | 1 | 2015 | 156 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 616 | 0.030 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 1188 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 1068 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 430 | 0.030 |
Why?
| | Middle Aged | 2 | 2020 | 36176 | 0.030 |
Why?
| | Clinical Competence | 1 | 2022 | 1242 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 780 | 0.020 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2594 | 0.020 |
Why?
| | Cytokinesis | 1 | 2013 | 50 | 0.020 |
Why?
| | Software | 1 | 2018 | 698 | 0.020 |
Why?
| | Mice, Nude | 1 | 2013 | 678 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2002 | 49 | 0.020 |
Why?
| | Lymphopenia | 1 | 2010 | 64 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1707 | 0.020 |
Why?
| | Immune System Phenomena | 1 | 2009 | 3 | 0.020 |
Why?
| | Tumor Cells, Cultured | 2 | 2002 | 883 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2008 | 32 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 50 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 120 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 320 | 0.020 |
Why?
| | Autoantibodies | 1 | 2015 | 1512 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 407 | 0.020 |
Why?
| | Thymus Gland | 1 | 2008 | 311 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 4283 | 0.020 |
Why?
| | HIV Infections | 1 | 2000 | 3189 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2009 | 525 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 14192 | 0.010 |
Why?
| | HLA-D Antigens | 1 | 2002 | 30 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 1020 | 0.010 |
Why?
| | Hybridomas | 1 | 2002 | 233 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2008 | 1112 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1468 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2002 | 247 | 0.010 |
Why?
| | Multigene Family | 1 | 2002 | 210 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2008 | 2499 | 0.010 |
Why?
| | Aged | 1 | 2020 | 26125 | 0.010 |
Why?
| | Leukemia, Erythroblastic, Acute | 1 | 1998 | 6 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1998 | 39 | 0.010 |
Why?
| | Granzymes | 1 | 1998 | 49 | 0.010 |
Why?
| | Cytoplasm | 1 | 1998 | 257 | 0.010 |
Why?
| | Serine Endopeptidases | 1 | 1998 | 129 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1998 | 396 | 0.010 |
Why?
| | Enzyme Activation | 1 | 1998 | 762 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40707 | 0.010 |
Why?
| | Cell Death | 1 | 1998 | 383 | 0.010 |
Why?
| | Immunity, Innate | 1 | 2002 | 846 | 0.010 |
Why?
| | Hot Temperature | 1 | 1998 | 411 | 0.010 |
Why?
| | Protein Binding | 1 | 1998 | 2250 | 0.010 |
Why?
| | Time Factors | 1 | 1998 | 7171 | 0.000 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|